A detailed history of Old Second National Bank Of Aurora transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Old Second National Bank Of Aurora holds 300 shares of GILD stock, worth $26,964. This represents 0.01% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$26,964
Previous $20,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$63.15 - $72.88 $4,988 - $5,757
-79 Reduced 20.84%
300 $20,000
Q1 2024

May 06, 2024

BUY
$71.58 - $87.29 $5,654 - $6,895
79 Added 26.33%
379 $27,000
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $8,662 - $12,436
-139 Reduced 31.66%
300 $25,000
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $8,050 - $10,088
139 Added 46.33%
439 $26,000
Q4 2021

Jan 25, 2022

SELL
$64.88 - $73.64 $9,018 - $10,235
-139 Reduced 31.66%
300 $20,000
Q3 2021

Dec 06, 2021

BUY
$67.69 - $73.03 $9,408 - $10,151
139 Added 46.33%
439 $31,000
Q3 2020

Oct 28, 2020

SELL
$62.1 - $78.08 $12,420 - $15,616
-200 Reduced 40.0%
300 $19,000
Q4 2019

Jan 21, 2020

SELL
$61.62 - $67.78 $24,648 - $27,112
-400 Reduced 44.44%
500 $32,000
Q2 2019

Jul 18, 2019

BUY
$61.87 - $69.38 $6,187 - $6,938
100 Added 12.5%
900 $61,000
Q1 2019

Apr 25, 2019

SELL
$62.53 - $70.05 $25,324 - $28,370
-405 Reduced 33.61%
800 $52,000
Q4 2018

Jan 18, 2019

BUY
$60.54 - $79.0 $36,626 - $47,795
605 Added 100.83%
1,205 $75,000
Q4 2017

Jan 17, 2018

SELL
$71.15 - $83.52 $166,633 - $195,603
-2,342 Reduced 79.61%
600 $43,000
Q3 2017

Oct 19, 2017

BUY
$72.11 - $85.47 $212,147 - $251,452
2,942
2,942 $239,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Old Second National Bank Of Aurora Portfolio

Follow Old Second National Bank Of Aurora and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Second National Bank Of Aurora, based on Form 13F filings with the SEC.

News

Stay updated on Old Second National Bank Of Aurora with notifications on news.